Cypherpunk Technologies Inc. (NasdaqCM: CYPH)
Health Care · Biotechnology · US
$1.68
+18.31% today · +358.1% 1Y
Cypherpunk Technologies Inc. (NasdaqCM: CYPH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $153.03M and employs 6 people.
Over the last twelve months the share price has gained 358.1%, trading between 0.27 and 3.70.
Tweenvest scores Cypherpunk Technologies Inc. across four factors: quality 42/100. Its strongest factor is quality.
CYPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $153.03M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- $3.70
- 52-week low
- $0.27
- Avg volume (3M)
- —
- Shares outstanding
- 107.76M
- Employees
- 6
- Next earnings
- —
About Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is to advance technologies that guarantee privacy for individuals on the internet, with a primary focus on investing in, accelerating the adoption of, and strengthening the ecosystem of Zcash, a privacy-preserving digital currency.
- ISIN
- US52187K2006
- Founded
- 2011
- Listed since
- Jan 25, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €864.20 | -4.19% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $138.89 | -4.26% |
Figures last refreshed Aug 18, 2026.